Candisil HCT 8 mg/12,5 mg tabletes Latvia - latvisk - Zāļu valsts aģentūra

candisil hct 8 mg/12,5 mg tabletes

laboratorios liconsa, s.a., spain - candesartanum cilexetilum, hydrochlorothiazidum - tablete - 8 mg/12,5 mg

Candisil HCT 32 mg/25 mg tabletes Latvia - latvisk - Zāļu valsts aģentūra

candisil hct 32 mg/25 mg tabletes

laboratorios liconsa, s.a., spain - candesartanum cilexetilum, hydrochlorothiazidum - tablete - 32 mg/25 mg

Ertapenem Qilu 1 g pulveris infūziju šķīduma koncentrāta pagatavošanai Latvia - latvisk - Zāļu valsts aģentūra

ertapenem qilu 1 g pulveris infūziju šķīduma koncentrāta pagatavošanai

qilu pharma spain s.l., spain - ertapenēms - pulveris infūziju šķīduma koncentrāta pagatavošanai - 1 g

Kestine 20 mg apvalkotās tabletes Latvia - latvisk - Zāļu valsts aģentūra

kestine 20 mg apvalkotās tabletes

almirall, s.a., spain - ebastīns - apvalkotā tablete - 20 mg

Kestine 10 mg apvalkotās tabletes Latvia - latvisk - Zāļu valsts aģentūra

kestine 10 mg apvalkotās tabletes

almirall, s.a., spain - ebastīns - apvalkotā tablete - 10 mg

Kestine 10 mg apvalkotās tabletes Latvia - latvisk - Zāļu valsts aģentūra

kestine 10 mg apvalkotās tabletes

almirall, s.a., spain - ebastīns - apvalkotā tablete - 10 mg

Meropenem Qilu 1 g pulveris injekciju/infūziju šķīduma pagatavošanai Latvia - latvisk - Zāļu valsts aģentūra

meropenem qilu 1 g pulveris injekciju/infūziju šķīduma pagatavošanai

qilu pharma spain s.l., spain - meropenēms - pulveris injekciju/infūziju šķīduma pagatavošanai - 1 g

Valsol plus 160 mg/25 mg apvalkotās tabletes Latvia - latvisk - Zāļu valsts aģentūra

valsol plus 160 mg/25 mg apvalkotās tabletes

laboratorios liconsa, s.a., spain - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 160 mg/25 mg

Valsol plus 80 mg/12,5 mg apvalkotās tabletes Latvia - latvisk - Zāļu valsts aģentūra

valsol plus 80 mg/12,5 mg apvalkotās tabletes

laboratorios liconsa, s.a., spain - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 80 mg/12,5 mg

Spikevax (previously COVID-19 Vaccine Moderna) Den europeiske union - latvisk - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcīnas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.